Europe Bioinformatics Market Forecast to 2028 – COVID

Europe Bioinformatics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Knowledge Management Tools, Bioinformatics Platforms, and Bio Informative Services), Application (Genomics, Chemo Informatics and Drug Design, Proteomics, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others)

Report Code : BMIRE00027482 | Region : Europe | Industry : Healthcare IT | Published Date : 16/Nov/2022

The Europe bioinformatics market is expected to grow from US$ 3,626.93 million in 2022 to US$ 8,615.56 million by 2028; it is estimated to grow at a CAGR of 15.5% from 2022 to 2028.

Increasing Funding and Investments in Bioinformatics Drives Market Growth

Many private organizations and government bodies of various countries in the region are progressively investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which have developed the quality of bioinformatics services. For instance, in 2016, the European Molecular Biology Laboratory (EMBL), an intergovernmental organization and pioneer in bioinformatics research, received funds from various organizations such as the British Heart Foundation, Biotechnology and Biological Sciences Research Council, European Molecular Biology Organization, Cancer Research UK, the European Research Council, the European Commission, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program, International Policy Governance Organization, the Medical Research Council, the National Institutes of Health, National Science Foundation, Parkinson's UK, Research Councils UK, and Wellcome, for R&D in the field of bioinformatics. Also, in 2021, LifeArc (London) announced US$ 6.91 million in funding to support the Gen OMICC COVID-19 study, which will also support the bioinformatics analysis of patients, costs of patient enrolment, sample acquisition, and sample processing. Many countries are investing in their national population sequencing programs to identify the link between genetics and diseases. Government organizations are sequencing the genomes of millions of citizens to advance research and help develop better techniques to diagnose and treat cancer, rare diseases, and other conditions. Thus, the funding and investment in bioinformatics are boosting the market growth across the region.

Market Overview

The European bioinformatics market is segmented into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the market in 2022. The growing importance of bioinformatics in drug development and rising initiatives by key players are aiding the market growth in Germany. For instance, in January 2022, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH launched a CRO named ProtaGene. It provides protein and gene analytic services for biological therapeutics and cell & gene therapy platforms, from discovery to commercialization. Protagen Protein Services, a global analytic CRO and specialist in protein science; BioAnalytix, US-based advanced analytics and data analysis firm; and GeneWerk, a company having unique capabilities in vector safety, integration site analysis, and bioinformatics, are a few companies operating in the market. In September 2019, Brooks Life Sciences Company’s GENEWIZ, a global bioinformatics services provider, opened its European headquarters for its genomics business in Leipzig, Germany. This centralized location helped accelerate the innovation and development of genomics research and applications in pharmaceutical, biotechnology, agriculture, environmental, clean energy, academic, and other industries in Europe. In February 2022, Nostos Genomics, a German startup, received a US$ 5.28 million investment for using Artificial Intelligence (AI) to diagnose rare genetic diseases. With the funding, Nostos can grow its development team, start a research series, and promote its genetic disease diagnosis technology to new markets in Europe. Thus, Germany continues to dominate the Europe bioinformatics market owing to rapid advancements in bioinformatics technologies and increased funding for genomic research using bioinformatics tools.

Europe Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)

Europe Bioinformatics Market Segmentation

The Europe bioinformatics market is segmented on the basis of product, application, sector, and country.

Based on product, the Europe bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held the largest market share in 2022. Based on application, the Europe bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2022. Based on sector, the Europe bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2022. Based on country, the Europe bioinformatics market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Further, Germany dominated the market in 2022. Agilent Technologies, Inc.; Biomax Informatics AG; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Genebio; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. are the leading companies operating in the Europe bioinformatics market.

At 15.5% CAGR, the Europe Bioinformatics Market is speculated to be worth US$ 8,615.56 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Europe bioinformatics market was valued at US$ 3,626.93 million in 2022 and is expected to reach US$ 8,615.56 million by 2028, registering an annual growth rate of 15.5% from 2022 to 2028. Increased number of genomic research activities with corresponding adoption of bioinformatics and increasing funding and investments in bioinformatics are the critical factors attributed to the market expansion.

In the field of genetics and genomics, the bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and more generally in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as to reduce health inequalities by providing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases that burden their populations. Currently, cancer treatment is also set to gain from genomic information to predict how an individual responds to drugs and inform prescription of the appropriate drug or dosage. The initiatives to generate and collect human genomic data is evolving rapidly and is highly diverse, with private and public initiatives across multiple countries. The increasing number of genomics activities along with rising adoption of bioinformatics is driving the market across the region.

On the contrary, lack of interoperability and multiplatform capabilities hurdles the growth of Europe bioinformatics market.

Based on product, the Europe bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held 49.2% market share in 2022, amassing US$ 1,782.64 million. It is projected to garner US$ 4,278.89 million by 2028 to expand at 15.7% CAGR during 2022–2028. Based on application, the Europe bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held 28.3% market share in 2022, amassing US$ 1,024.93 million. It is projected to garner US$ 2,457.48 million by 2028 to expand at 15.7% CAGR during 2022–2028. Based on sector, the Europe bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held 27.3% market share in 2022, amassing US$ 989.93 million. It is projected to garner US$ 2,448.38 million by 2028 to expand at 16.3% CAGR during 2022–2028. Based on country, the Europe bioinformatics market has been categorized into the UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 26.6% market share in 2022. It was assessed at US$ 963.10 million in 2022 and is likely to hit US$ 2,311.82 million by 2028, exhibiting a CAGR of 15.7% during the forecast period. Key players dominating the Europe bioinformatics market are Agilent Technologies, Inc.; Biomax Informatics AG; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Genebio; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. among others.

In April 2021, Agilent Technologies, Inc. announced that it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. In May 2022, QIAGEN N.V. announced that it has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A., a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland. BLIRT develops, manufactures, and commercializes standardized and customized solutions for proteins and enzymes as well as molecular biology reagents.

TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

1.2.1 Europe Bioinformatics Market – By Product

1.2.2 Europe Bioinformatics Market – By Application

1.2.3 Europe Bioinformatics Market – By Sector

1.2.4 Europe Bioinformatics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Bioinformatics Market – Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Expert Opinion

5. Europe Bioinformatics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Funding and Investments in Bioinformatics

5.1.2 Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics

5.2 Market Restraint

5.2.1 Lack of Interoperability and Multiplatform Capabilities

5.3 Market Opportunities

5.3.1 Rising Demand for Personalized Medicine

5.4 Future Trends

5.4.1 Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics

5.5 Impact Analysis

6. Bioinformatics Market – Europe Analysis

6.1 Europe Bioinformatics Market Revenue Forecast & Analysis

7. Europe Bioinformatics Market Analysis – By Product

7.1 Overview

7.2 Europe Bioinformatics Market Revenue Share by Product (2022 and 2028)

7.3 Bioinformatics Platforms

7.3.1 Overview

7.3.2 Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

7.4 Knowledge Management Tools

7.4.1 Overview

7.4.2 Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

7.5 Bioinformative Services

7.5.1 Overview

7.5.2 Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8. Europe Bioinformatics Market Analysis – By Application

8.1 Overview

8.2 Europe Bioinformatics Market Revenue Share, by Application (2022 and 2028)

8.3 Genomics

8.3.1 Overview

8.3.2 Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8.4 Proteomics

8.4.1 Overview

8.4.2 Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8.5 ChemoInformatics and Drug Design

8.5.1 Overview

8.5.2 ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8.6 Transcriptomics

8.6.1 Overview

8.6.2 Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8.7 Metabolomics

8.7.1 Overview

8.7.2 Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

9. Europe Bioinformatics Market Analysis – By Sector

9.1 Overview

9.2 Europe Bioinformatics Market Share, by Sector, 2022 and 2028, (%)

9.3 Medical Biotechnology

9.3.1 Overview

9.3.2 Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

9.4 Animal Biotechnology

9.4.1 Overview

9.4.2 Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

9.5 Agricultural Biotechnology

9.5.1 Overview

9.5.2 Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

9.6 Academics

9.6.1 Overview

9.6.2 Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

9.7 Environmental Biotechnology

9.7.1 Overview

9.7.2 Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

9.8 Forensic Biotechnology

9.8.1 Overview

9.8.2 Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

10. Europe Bioinformatics Market – Country Analysis

10.1 Overview

10.1.2 Europe: Bioinformatics Market, by Country, 2022 & 2028 (%)

10.1.2.1 UK: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 UK: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 UK: Bioinformatics Market, by Product, 2019–2028 (USD Million)

10.1.2.1.3 UK: Bioinformatics Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 UK: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

10.1.2.2 Germany: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Germany: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Germany: Bioinformatics Market, by Product, 2019–2028 (USD Million)

10.1.2.2.3 Germany: Bioinformatics Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Germany: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

10.1.2.3 France: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 France: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 France: Bioinformatics Market, by Product, 2019–2028 (USD Million)

10.1.2.3.3 France: Bioinformatics Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 France: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

10.1.2.4 Italy: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Italy: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Italy: Bioinformatics Market, by Product, 2019–2028 (USD Million)

10.1.2.4.3 Italy: Bioinformatics Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Italy: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

10.1.2.5 Spain: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1 Overview

10.1.2.5.2 Spain: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3 Spain: Bioinformatics Market, by Product- 2019–2028 (USD Million)

10.1.2.5.4 Spain: Bioinformatics Market, by Application- 2019–2028 (USD Million)

10.1.2.5.5 Spain: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

10.1.2.6 Rest of Europe: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1 Overview

10.1.2.6.2 Rest of Europe: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3 Rest of Europe: Bioinformatics Market, by Product- 2019–2028 (USD Million)

10.1.2.6.4 Rest of Europe: Bioinformatics Market, by Application- 2019–2028 (USD Million)

10.1.2.6.5 Rest of Europe: Bioinformatics Market, by Sector, 2019–2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. COMPANY PROFILES

12.1 Dassault Systèmes

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Bruker Corporation

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Agilent Technologies, Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Eurofins Scientific

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Illumina, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 QIAGEN

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Thermo Fisher Scientific Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Biomax Informatics AG

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Genebio

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. Europe Bioinformatics Market – Revenue and Forecast to 2028 (US$ Mn)

Table 2. UK: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. UK: Bioinformatics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. UK: Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Bioinformatics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. France: Bioinformatics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10. France: Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (US$ Million)

Table 11. Italy: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 12. Italy: Bioinformatics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13. Italy: Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (US$ Million)

Table 14. Spain Bioinformatics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain Bioinformatics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Spain Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe Bioinformatics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe Bioinformatics Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of Europe Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (USD Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms

LIST OF FIGURES.

Figure 1. Europe Bioinformatics Market Segmentation

Figure 2. Europe Bioinformatics Segmentation, by Country

Figure 3. Europe Bioinformatics Market Overview

Figure 4. Europe Bioinformatics Market, By Product

Figure 5. Europe Bioinformatics Market, By Country

Figure 6. Europe PEST Analysis

Figure 7. Europe Bioinformatics Market Impact Analysis of Drivers and Restraints

Figure 8. Europe Bioinformatics Market – Revenue Forecast and Analysis

Figure 9. Europe Bioinformatics Market Revenue Share by Product (2022 and 2028)

Figure 10. Europe Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 11. Europe Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 12. Europe Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 13. Europe Bioinformatics Market Revenue Share, by Application (2022 and 2028)

Figure 14. Europe Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 15. Europe Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 16. Europe ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 17. Europe Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 18. Europe Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 19. Europe Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 20. Europe Bioinformatics Market Share, by Sector, 2022 and 2028 (%)

Figure 21. Europe Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 23. Europe Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 24. Europe Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Europe Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe: Bioinformatics Market, by Key Country – Revenue (2022) (USD Million)

Figure 29. Europe: Bioinformatics Market, by Country, 2022 & 2028 (%)

Figure 30. UK: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Germany: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. France: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Italy: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Spain: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Rest of Europe: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Europe Bioinformatics Market

● Agilent Technologies, Inc.

● Biomax Informatics AG

● Bruker Corporation

● Dassault Systèmes

● Eurofins Scientific

● Genebio

● Illumina, Inc.

● PerkinElmer Inc.

● QIAGEN  

● Thermo Fisher Scientific Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioinformatics market.

● Highlights key business priorities to assist companies to realign their business s strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Europe bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP